Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Moodys
Express Scripts
Boehringer Ingelheim
McKinsey
Merck
Medtronic

Last Updated: December 12, 2019

DrugPatentWatch Database Preview

Prednicarbate - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What are the generic sources for prednicarbate and what is the scope of freedom to operate?

Prednicarbate is the generic ingredient in three branded drugs marketed by Valeant Bermuda, Fougera Pharms, and Valeant Pharms North, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for prednicarbate. Two suppliers are listed for this compound.

Drug Prices for prednicarbate

See drug prices for prednicarbate

Recent Clinical Trials for prednicarbate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Handok Pharmaceuticals Co., Ltd.Phase 4

See all prednicarbate clinical trials

Pharmacology for prednicarbate
Synonyms for prednicarbate
(11|A)-17-[(Ethoxycarbonyl)oxy]-11-hydroxy-21-(1-oxopropoxy)pregna-1,4-diene-3,20-dione
[2-[(8S,9S,10R,11S,13S,14S,17R)-17-ethoxycarbonyloxy-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] propanoate
[2-[(8S,9S,10R,11S,13S,14S,17R)-17-ethoxycarbonyloxy-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] propanoate
11beta,17,21-Trihydroxypregna-1,4-diene-3,20-dione 17-(ethyl carbonate) 21-propionate
73771-04-7
771P047
AB00514017
AB2000755
AC-3521
AC1O8Q04
AKOS025402043
AN-6763
API0009173
BC226387
BPBio1_001066
BRD-K46137903-001-03-3
BSPBio_000968
CAS-73771-04-7
CCG-221044
CHEBI:135791
CHEMBL1200386
D05601
DB01130
Dermatop
Dermatop (TN)
Dermatop E emollient
DSSTox_CID_25502
DSSTox_GSID_45502
DSSTox_RID_80919
DTXSID9045502
EINECS 277-590-3
GTPL7605
HMS1571A10
HMS2098A10
HMS2230O11
HMS3715A10
Hoe 777
Hoe-777
MLS002154121
NCGC00016926-01
NCGC00179357-01
Peitel
Prednicarbat
Prednicarbate (USP/INN)
Prednicarbate [USAN:USP:INN:BAN]
Prednicarbato
Prednicarbato [INN-Spanish]
Prednicarbatum
Prednicarbatum [INN-Latin]
Prednisolone 17-(Ethyl Carbonate) 21-Propionate
Prednitop
Pregna-1,4-diene-3,20-dione, 17-((ethoxycarbonyl)oxy)-11-hydroxy-21-(1-oxopropoxy)-, (11beta)-
Pregna-1,4-diene-3,20-dione,17-[(ethoxycarbonyl)oxy]-11-hydroxy-21-(1-oxopropoxy)-, (11b)-
Prestwick0_001044
Prestwick1_001044
Prestwick2_001044
Prestwick3_001044
Q-101379
Regenit
S 77 0777
S 77-0777
S 770777
S-77 0777
S-770777
SC-81331
SCHEMBL3941
SMR001233428
SPBio_002904
SR-01000841201
SR-01000841201-2
Tox21_110687
UNII-V901LV1K7D
V901LV1K7D
ZINC3938652

US Patents and Regulatory Information for prednicarbate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera Pharms PREDNICARBATE prednicarbate CREAM;TOPICAL 077287-001 Sep 19, 2006 AB RX No No   Start Trial   Start Trial   Start Trial
Valeant Pharms North DERMATOP prednicarbate OINTMENT;TOPICAL 019568-001 Sep 23, 1991 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Valeant Bermuda DERMATOP E EMOLLIENT prednicarbate CREAM;TOPICAL 020279-001 Oct 29, 1993 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for prednicarbate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant Bermuda DERMATOP E EMOLLIENT prednicarbate CREAM;TOPICAL 020279-001 Oct 29, 1993   Start Trial   Start Trial
Valeant Pharms North DERMATOP prednicarbate OINTMENT;TOPICAL 019568-001 Sep 23, 1991   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Boehringer Ingelheim
Harvard Business School
AstraZeneca
Baxter
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.